Kimmie Ng, MD, MPH
Medical Oncology
Dr. Kimmie Ng is Associate Chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute, and an Associate Professor of Medicine at Harvard Medical School in Boston, MA. She serves as Co-Director of the Colon and Rectal Cancer Center and the Director of Translational Research in the division. She is also the Founding Director of the Young-Onset Colorectal Cancer Center at Dana-Farber, one of the first of its kind in the country. Her research focuses on identifying dietary, plasma, and molecular predictors of improved survival in patients with colorectal cancer, with a special interest in the vitamin D pathway, the microbiome, and young-onset colorectal cancer. Her research has been funded by the National Cancer Institute, Cancer Research UK, U.S. Department of Defense, and other foundation and industry grants. She has been featured in multiple national media outlets, including the TODAY Show, MSNBC, ABC News, The New York Times, CNN, The Washington Post, and the Wall Street Journal, to raise awareness of young-onset colorectal cancer and the importance of cancer screening.
Dr. Ng's clinical practice involves the care of patients with all types of gastrointestinal cancers. As Director of Translational Research, she oversees the Gastrointestinal Cancer Biobank and facilitates translational research projects with academic and industry collaborators. She is also involved in the design and conduct of clinical trials, and has served as Principal Investigator of several national multi-center randomized trials.
Dr. Ng obtained her Bachelor of Science degree with Distinction from Yale University and her Doctor of Medicine degree from University of Pennsylvania Perelman School of Medicine. She completed her residency in internal medicine at University of California, San Francisco (UCSF) and a medical oncology fellowship at Dana-Farber/Partners CancerCare. She subsequently received a Master of Public Health degree from Harvard T.H. Chan School of Public Health.
